Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update; exclusivity agreement with Microsaic

20 Dec 2023 12:30

RNS Number : 4962X
Deepverge PLC
20 December 2023
 

20 December 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company")

 

Update; exclusivity agreement with Microsaic

 

Further to the previous notification on 13 December 2023, the Company has today entered into an agreement with Microsaic Systems plc ("Microsaic") granting Microsaic a period of exclusivity ("Exclusivity Period") in respect of the potential sale of certain assets currently held within subsidiaries relating to its Modern Water business ("the 'Business").

The assets broadly comprise equipment for the laboratory-based manufacturing of bio-reagents used in related water testing equipment currently based at the Company's York laboratory and include all IP and rights to the related water testing equipment including LX, FX and Continuous Toxic Measuring ("CTM") machines and water membrane technology.

The Business specifically excludes the voltammetry technology and equipment manufactured by B3 Electronic Design Pty Ltd in Perth, Australia.

The granting of the Exclusivity Period follows the receipt of an indicative outline proposal from Microsaic to purchase the Business for £100,000 in cash payable on completion ('the Proposal').

 

In addition upon completion Microsaic Systems is willing to discharge all intra company debt (sum to be verified) between DeepVerge and Microsaic as part of the consideration for the acquisition.

 

The Exclusivity Period runs until the earlier of (a) 16 January 2024, (b) the signature of a legally binding sale & purchase agreement between the DeepVerge and Microsaic for the Business ("the Transaction") and (c) withdrawal of the Proposal by Microsaic.

No consideration has been received by DeepVerge for the granting of the Exclusivity Period.

During the Exclusivity Period DeepVerge shall not solicit, advertise, market or enter any other negotiations, arrangements or options with any third parties relating to the sale of the Business and shall not complete the Transaction other than with Microsaic.

The Exclusivity Period may, at its sole discretion, be extended by Deepverge for a further period for the Transaction to be finalised.

The Exclusivity Period is designed to provide Microsaic with time to conclude its due diligence, obtain binding commitments for a fundraising, including working capital for the enlarged Microsaic business, and consideration for the Transaction, and to negotiate and sign a detailed sale and purchase agreement. There is no guarantee that the Transaction will occur, or that the outline terms indicated in the Proposal will be those on which a binding agreement is signed. As previously notified on 13 December 2023, any proceeds from a disposal transaction is likely to realise insufficient value to avoid the closure or administration of the relevant Group subsidiaries.

DeepVerge director Dr Nigel Burton is also a director of Microsaic. Given his conflict of interest, Dr Burton is not involved in the DeepVerge board's consideration of the Transaction. Ross Andrews is the only independent director ("Independent Director").

As previously notified, the cancellation of the admission of the Company's shares to trading on AIM ("Cancellation") is expected therefore to take place with effect from 7.00 a.m. on 27 December 2023.

If the Transaction occurs before the date of Cancellation it would constitute a related party transaction under the AIM Rules for Companies (the "AIM Rules") and would require treatment in accordance with AIM Rule 13 (related party transactions) and AIM Rule 15.

The Company will no longer be subject to the AIM Rules once Cancellation has occurred. In the event that Cancellation occurs before a binding agreement is entered into for the sale of the Business to Microsaic, the requirements of AIM Rule 13 and 15 would cease to apply to the transaction.

The Independent Director expects that if the Transaction occurs, it is likely to occur at a point following Cancellation.

Further updates will be given as appropriate.

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMZZZGRGFZM
Date   Source Headline
21st Oct 20217:00 amRNS2nd Generation Microtox® PD equipment shipping
15th Oct 20217:00 amRNSRelated Party Transaction
6th Oct 20217:00 amRNSDVRG engages with Media.Monks re Skin Trust Club
20th Sep 20217:00 amRNSSponsor at Reuters Conference on Climate Change
15th Sep 20217:01 amRNSIndia Centre of Excellence for Modern Water AMBC
15th Sep 20217:00 amRNSInterim Results
3rd Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Aug 20217:00 amRNSContinued progress thru' Microsaic collaboration
26th Jul 202112:25 pmRNSResult of AGM
26th Jul 20217:00 amRNSUpdate
12th Jul 20217:00 amRNSAppointment of Group Marketing Officer
7th Jul 20211:16 pmRNSExercise of Options and Total Voting Rights
30th Jun 20215:28 pmRNSNotice of AGM
30th Jun 20215:28 pmRNSFinal Results
25th Jun 20212:55 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSMicrotox Successful Phase 3 Field Trials
23rd Jun 20211:15 pmRNSResult of General Meeting
7th Jun 202112:23 pmRNS£10m Firm /Cond'l Placings & Subs - replacement
7th Jun 20219:35 amRNSFirm & Cond'l Placings & Subscription for £10m
6th May 20217:00 amRNSNew AI centre of excellence in Cork
30th Apr 20215:25 pmRNSExercise of Warrants and Total Voting Rights
30th Apr 20217:00 amRNSExercise of Warrants and Total Voting Rights
28th Apr 20217:00 amRNSDeepVerge signs MoU for JV with China Resources
26th Apr 20217:00 amRNSSkin Trust Club iOS App goes live
22nd Apr 20212:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20212:01 pmRNSPrice Monitoring Extension
21st Apr 20213:00 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20212:34 pmRNSExercise of Warrants and Total Voting Rights
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20213:43 pmRNSExercise of Options and Total Voting Rights
31st Mar 20217:00 amRNSUpdates on Labskin, Modern Water, Skin Trust Club
25th Mar 20213:43 pmRNSDeepVerge Investor Presentation
24th Mar 20213:37 pmRNSExercise of Warrants and Total Voting Rights
24th Mar 20212:05 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNS3 year Technology & Comm'l Agreem't with Microsaic
23rd Mar 20219:48 amRNSExercise of Warrants and Total Voting Rights
17th Mar 20214:22 pmRNSExercise of Warrants and Total Voting Rights
17th Mar 20217:00 amRNSMicrotox® BT Eval'n of SARS-CoV-2 from breath test
12th Mar 202111:23 amRNSAward Nomination in China
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20217:00 amRNSChange of interests of significant shareholder
5th Mar 20213:05 pmRNSExercise of Warrants and Total Voting Rights
2nd Mar 20217:00 amRNSEcowaterOS and Microtox PD Event in China
26th Feb 202112:11 pmRNSExercise of Warrants and Total Voting Rights
17th Feb 20217:00 amRNSProd'n orders worth $5m for Modern Water Equipment
15th Feb 20217:00 amRNSProposed Framework Services Ag'ment with Microsaic
10th Feb 20217:00 amRNSDeepverge adds two virus containment laboratories
8th Feb 20217:00 amRNSDirector/PDMR Shareholding
1st Feb 20215:45 pmRNSExercise of Warrants and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.